Comparing the Clinical Trial Characteristics of Industry-Funded Trials and Non Industry-Funded Trials

被引:0
|
作者
Hughes, Emily [1 ]
Van Bakel, Tamara [2 ]
Raudanskis, Ashley [1 ]
Ray, Prachi [1 ]
Hodzic-Santor, Benazir [1 ]
Purohit, Ushma [1 ]
Sacks, Chana A. [3 ,4 ]
Fralick, Michael [1 ,2 ]
机构
[1] Sinai Hlth Syst, Div Gen Internal Med, Toronto, ON, Canada
[2] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada
[3] Harvard Med Sch, Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA USA
[4] Harvard Med Sch, Massachusetts Gen Hosp, Mongan Inst, Boston, MA USA
来源
JOURNAL OF LAW MEDICINE & ETHICS | 2024年 / 52卷 / 03期
关键词
Randomized Controlled Trials; Funder; Trial Characteristics; Pharmaceutical; Industry; Natural Language Processing;
D O I
10.1017/jme.2024.135
中图分类号
B82 [伦理学(道德学)];
学科分类号
摘要
We compared study characteristics of randomized controlled trials funded by industry (N=697) to those not funded by industry (N=835). RCTs published in high-impact journals are more likely to be blinded, more likely to include a placebo, and more likely to post trial results on ClinicalTrials.gov. Our findings emphasize the importance of evaluating the quality of an RCT based on its methodological rigor, not its funder type.
引用
收藏
页码:693 / 700
页数:8
相关论文
共 50 条